SCND — Scientific Industries Income Statement
0.000.00%
- $9.24m
- $6.67m
- $10.71m
- 31
- 56
- 31
- 33
Annual income statement for Scientific Industries, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7.78 | 9.78 | 11.4 | 11.1 | 10.7 |
Cost of Revenue | |||||
Gross Profit | 3.94 | 4.98 | 5.74 | 5.1 | 4.73 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8.45 | 14.5 | 19.1 | 20.4 | 17.4 |
Operating Profit | -0.663 | -4.71 | -7.7 | -9.26 | -6.64 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.667 | -4.05 | -7 | -9.09 | -6.45 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.453 | -3.11 | -5.65 | -9.09 | -6.45 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -0.703 | -3.67 | -5.64 | -9.09 | -6.45 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.703 | -3.67 | -5.64 | -9.09 | -6.45 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.299 | -0.975 | -0.809 | -0.896 | -0.614 |